Initial Clinical and CBCT Outcomes of Enamel Matrix Derivative-Based Regenerative Therapy in Vertical Bone Defects

NCT06639555 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Vertical Alveolar Bone Loss

Interventions

PROCEDURE: PRP( platelet rich plasma)
PROCEDURE: EMD (Enamel Matrix Derivative)
PROCEDURE: Guided Tissue Regeneration (barrier membrane)
PROCEDURE: Guided Tissue Regeneration(barrier membrane and PRP)

Sponsor

Tsvetalina Gerova-Vatsova